Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Breast Cancer-OFS Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
ASH 2016 Highlights
CAR T-Cell Therapy Succeeds in Aggressive Lymphoma
By
Phoebe Starr
ASH 2016 Highlights
February 2017, Vol 7, No 2
Read More ›
Obinutuzumab Prolongs Survival in Follicular Lymphoma
By
Phoebe Starr
ASH 2016 Highlights
February 2017, Vol 7, No 2
Read More ›
Glasdegib, a Hedgehog Inhibitor, Nearly Doubles Survival in Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
By
Wayne Kuznar
ASH 2016 Highlights
February 2017, Vol 7, No 2
Read More ›
Triplet Therapy That Includes Elotuzumab Stops Progression of High-Risk Smoldering Multiple Myeloma
By
Wayne Kuznar
ASH 2016 Highlights
,
Multiple Myeloma
,
Hematologic Malignancies
February 2017, Vol 7, No 2
Read More ›
Strategies to Reduce the Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
By
Phoebe Starr
ASH 2016 Highlights
February 2017, Vol 7, No 2
Read More ›
R-CHOP Prevails Over Dose-Adjusted EPOCH-R as Standard of Care for Diffuse Large B-Cell Lymphoma
By
Phoebe Starr
ASH 2016 Highlights
February 2017, Vol 7, No 2
Read More ›
New Value Model Incorporates Long-Term Adverse Effects of Cancer Drugs
By
Chase Doyle
ASH 2016 Highlights
February 2017, Vol 7, No 2
Read More ›